Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulin.
对接受帕博利珠单抗和艾立布林治疗的激素受体阳性、HER2阴性转移性乳腺癌患者的肠道和口腔微生物群进行分析
期刊:Microbiome Research Reports
影响因子:3.800
doi:10.20517/mrr.2024.49
Teng Nancy My, Malfettone Andrea, Dalby Matthew J, Kiu Raymond, Seki David, Robinson Tim, Gion MarÃa, Bermejo Begoña, Pérez-GarcÃa José Manuel, Prat Aleix, Vázquez Raúl Márquez, Llombart-Cussac Antonio, Curigliano Giuseppe, Schmid Peter, Barroso-Sousa Romualdo, Mancino Mario, Shimizu Eileen, RodrÃguez-Morató Jose, Mina Leonardo, Hall Lindsay J, Robinson Stephen D, Cortés Javier